Grainger Increases Quarterly Dividend By 6.3 Percent
CHICAGO, April 25, 2018/PRNewswire/ -- W.W. Grainger, Inc. (NYSE: GWW) announced today that its board of directors voted to raise the quarterly cash dividend by 6.3 percent to $1.36 per share payable on June 1, 2018, to shareholders of record on May 14, 2018. Grainger has delivered 47 consecutive years of increased dividends.
"Our consistent history of increasing the dividend illustrates our confidence in our strategy and our focus on managing the business for the long term while creating value for our shareholders," said Grainger Chairman and CEO DG Macpherson.
About Grainger W.W. Grainger, Inc., with 2017 sales of $10.4 billion, is North America's leading broad line supplier of maintenance, repair and operating products (MRO), with operations also in Europe, Asia and Latin America.
Exodus Movement, Inc. (the "Company" or "Exodus") today announced that it was informed by the NYSE American that the exchange has delayed the Company's listing until the Staff of the Securities and Exchange Commission completes its review of Exodus'...
Forward Air Corporation (the "Company", "Forward", "we", "our", or "us") today reported financial results for the three months ended March 31, 2024 as presented in the tables below on a continuing operations basis (Final Mile is being reported as a...
To the Holders of Common Shares of Labrador Iron Ore Royalty Corporation
The Directors of Labrador Iron Ore Royalty Corporation ("LIORC" or the "Corporation") present the first quarter report for the period ended March 31, 2024.
Financial...
Copart, Inc. announced today that it will release earnings for the third quarter of fiscal 2024 after 4:00 p.m. Eastern Time (3:00 p.m. Central) on Thursday, May 16, 2024.
On Thursday, May 16, 2024, at 5:30 p.m. Eastern Time (4:30 p.m. Central),...
Western Forest Products Inc. ("Western" or the "Company") announces the following voting results in respect of the election of directors at its Annual Meeting of Shareholders (the "Meeting") held today: Name of NomineeVotes For% ForVotes Against%...
Organovo Holdings, Inc. ("Organovo" or the "Company"), a clinical stage biotechnology company focused on developing novel treatment approaches based on demonstration of clinical promise in three-dimensional (3D) human tissues, today announced the...
